EXERCISE TESTS

Dr. Paulo Gurgel

EXERCISE TESTS
• • • • •
Cooper test test Rockport Walking Test 6 Minutes Ergometry Cardiopulmonary Exerc
ise Test
KENNETH COOPER • 1968: "Aerobics"
1970: Cooper Aerobics Center
Cooper 12 minutes test
The maximum distance that someone can walk / run in 12 minutes.
Cooper test
• • • • Gender (M or F) Age (years) Distance (m) Rating: Excellent - Above Avera
ge - Average - Below Average - Low • Average
- M: 2700 (17-20 years) to 1600 (> 50 years) meters - F: 2200 (20-29 years) to 1
400 (> 50 years) meters
Cooper test of VO2 max estimate
Distance - 504.9: 44.73 (mL.kg-1.min-1)
In the savannah ...
Test Rockport 1 mile = 1609 m
• • • • •
Gender (M or F) Age (years) Weight (kg) post-test heart rate hike duration (minu
tes)
Rockport Test
• Calculation of VO2 max and METs (*): available through programs at RMC • VO2ma
x calculated: position in the gender and age group • Rating: Excellent - Good -
Above Average - Average - Below Average - Poor - Very Bad
(*) = 3.5 mL.kg-1.min-1 The consumption
Walk test
• McGavin et al. Twelve minutes walking test for Assessing disability in chronic
bronchitis. British Medical Journal, 1976 • Validation for 6 minutes • Security
- Autoregulável - submaximal effort - Monitoring
• Reproducibility
Test 6-minute walk (6MWT)
SpO2 • • • • Gender (M or F) Age (years) Weight (kg) Height (m) FR FC Distance B
org Others Before After * * * * * * * * * * *
Walking distance normal values and lower limits
VN M (meters) = 1140 - (5,61 x BMI) - (6.94 X age) LI (meters) = VN - VN 153
F (meters) = 1017 - (6,24 x BMI) - (5.83 x age) LI (in meters) = VN - 139 e
quations of Enright and Sherril
Interpretation
• Abnormal (DC <LI)
- With the fall of SpO2 ≥ 4% compatible with diffusion disorder - with RR> 50/
min compatible with respiratory disorder - With FC> FC ≤ basal or submaximal
compatible with circulatory disorder
• Normal
Indications
• Assessment of disability • Rehabilitation: indication, monitoring and evaluati
on of results of dyspnea • Research • Prescription of oxygen • Preoperative eval
uation • Estimating prognosis
BODE score
PT # 1 to 58 FEV1: 28% MRC: 2 / 4 PaO2: 70 mmHg TC 6M: 540 m BMI: 30 BODE: 3 BOD
E PT # 2 62 to FEV1: 33% MRC: 2 / 4 PaO2: 57 mmHg TC 6M : 400 m BMI: 21 BODE: 6
Claudia Cote, MD # 3 PT 69 and FEV1: 35% MRC: 3 / 4 PaO2: 66 mmHg TC 6M: 230 m B
MI: 34 BODE: 7
1
2
3
4
FEV1 <35%
PT # 4 FEV1 72 to 34% MRC: 4 / 4 PaO2: 60 mmHg TC 6M: 154 m BMI: 24 BODE: 9
Ergometry
• Method to evaluate the clinical responses, electrocardiographic and hemodynami
c front of a progressive physical effort performed on a treadmill or cycle ergom
eter, with speed and slope variables as protocols. • Example:
- Bruce
• Reading Source: National Consensus Ergonometry
Indications of ergometry
• In disease research
- Coronary artery disease - Hypertension - Cardiac arrhythmias - Other: IC, MP,
MP
• In the healthy population or apparently normal
- Positive family history - Special Occupations - Fitness Programs
• In assessments
- Expert - Surgical Risk
VO2 max equation for error: ± 20%
In no other area of biological knowledge a mistake of this magnitude (± 20%) is
tolerated. For example, would would accept that for a person with 170 cm height,
70 kg, 200 mg / dl blood cholesterol and a maximum heart rate of 180 bpm, we co
uld have measured values, with 20% error, more or less getting any result betwee
n 136 and 214 cm high, 56 and 84 kg, 160 and 240 mg / dl cholesterol and 144 or
214 bpm maximum heart rate? Dr. Claudio Gil, medical director of Clinimex
+ = Test Spirometry ergometry cardiopulmonary exercise (CPX)
Ergometers
Ergometers special
Ergometers special
CPET
Direct measurements
O2 consumption (VO2 FEO2) Production of CO2 (VCO2 FECO2) Pulmonary ventilati
on (VC x FR LV) heart rate (HR)
Monitoring
ECG SpO2 PA Sensation exertion
Ramp protocol
Power (W) Calories
Parameters derived
Bookmarks
Anaerobic threshold Respiratory compensation point maximal aerobic power
CPX - integrated
CPET with telemetry
CPX in Pulmonology
• Evaluation of the occurrence and etiology of exercise intolerance and its quan
tification • Evaluation of the indication of therapeutic response and its progno
sis in CKD • Analysis • Risk preoperative and postoperative evaluation • lung tr
ansplantation • Pulmonary Rehabilitation • Diagnosis by bronchial Exercise • Eva
luation of dysfunction and disability in DPO
BTS - Guidelines for Pulmonary Function Test, 2002
Test drive
GRATEFUL FOR ATTENTION
pgcs@ig.com.br